Farallon Capital Management as of Dec. 31, 2019
Portfolio Holdings for Farallon Capital Management
Farallon Capital Management holds 112 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr S&p 500 Etf (SPY) | 11.3 | $1.4B | 4.4M | 321.86 | |
| IAC/InterActive | 4.1 | $515M | 2.1M | 249.11 | |
| Fidelity National Information Services (FIS) | 3.9 | $485M | 3.5M | 139.09 | |
| Wabtec Corporation (WAB) | 3.2 | $394M | 5.1M | 77.80 | |
| Anthem (ELV) | 3.0 | $378M | 1.3M | 302.03 | |
| Alphabet Inc Class C cs (GOOG) | 3.0 | $368M | 275k | 1337.02 | |
| Vaneck Vectors Semiconductor Etf semiconductor (SMH) | 2.8 | $354M | 2.5M | 141.41 | |
| Microsoft Corporation (MSFT) | 2.8 | $345M | 2.2M | 157.70 | |
| Charter Communications Inc New Cl A cl a (CHTR) | 2.7 | $331M | 683k | 485.08 | |
| Cigna Corp (CI) | 2.5 | $307M | 1.5M | 204.49 | |
| Iqvia Holdings (IQV) | 2.3 | $287M | 1.9M | 154.51 | |
| Visa (V) | 2.3 | $286M | 1.5M | 187.90 | |
| Medicines Company | 2.3 | $282M | 3.3M | 84.94 | |
| salesforce (CRM) | 2.2 | $281M | 1.7M | 162.64 | |
| Thermo Fisher Scientific (TMO) | 2.2 | $277M | 853k | 324.87 | |
| Palo Alto Networks (PANW) | 2.1 | $256M | 1.1M | 231.25 | |
| Playa Hotels & Resorts Nv (PLYA) | 2.1 | $257M | 31M | 8.40 | |
| Equinix (EQIX) | 1.9 | $243M | 416k | 583.70 | |
| Alibaba Group Holding (BABA) | 1.9 | $240M | 1.1M | 212.10 | |
| Zayo Group Hldgs | 1.9 | $236M | 6.8M | 34.65 | |
| Abbvie (ABBV) | 1.8 | $221M | 2.5M | 88.54 | |
| Sherwin-Williams Company (SHW) | 1.7 | $215M | 368k | 583.54 | |
| Facebook Inc cl a (META) | 1.7 | $212M | 1.0M | 205.25 | |
| Ihs Markit | 1.7 | $207M | 2.7M | 75.35 | |
| Ascendis Pharma A S (ASND) | 1.4 | $178M | 1.3M | 139.12 | |
| S&p Global (SPGI) | 1.4 | $175M | 640k | 273.05 | |
| General Dynamics Corporation (GD) | 1.4 | $173M | 981k | 176.35 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $173M | 6.3M | 27.68 | |
| Alnylam Pharmaceuticals (ALNY) | 1.3 | $167M | 1.5M | 115.17 | |
| Myokardia | 1.2 | $149M | 2.1M | 72.88 | |
| Exelixis (EXEL) | 1.1 | $132M | 7.5M | 17.62 | |
| Transunion (TRU) | 1.1 | $131M | 1.5M | 85.61 | |
| Amarin Corporation (AMRN) | 0.9 | $110M | 5.1M | 21.44 | |
| Enanta Pharmaceuticals (ENTA) | 0.9 | $108M | 1.8M | 61.78 | |
| Acceleron Pharma | 0.8 | $106M | 2.0M | 53.02 | |
| Equifax (EFX) | 0.7 | $91M | 652k | 140.12 | |
| Zogenix | 0.7 | $91M | 1.8M | 52.13 | |
| Rts/bristol-myers Squibb Compa | 0.7 | $91M | 30M | 3.01 | |
| Broadmark Rlty Cap | 0.7 | $92M | 7.2M | 12.75 | |
| Anixter International | 0.7 | $85M | 918k | 92.10 | |
| Zymeworks | 0.6 | $77M | 1.7M | 45.46 | |
| Grifols S A Sponsored Adr R (GRFS) | 0.6 | $73M | 3.1M | 23.29 | |
| Qiagen Nv | 0.6 | $73M | 2.2M | 33.80 | |
| Audentes Therapeutics | 0.6 | $71M | 1.2M | 59.84 | |
| Chemocentryx | 0.5 | $59M | 1.5M | 39.55 | |
| Agios Pharmaceuticals (AGIO) | 0.5 | $60M | 1.3M | 47.75 | |
| Global Blood Therapeutics In | 0.5 | $60M | 750k | 79.49 | |
| Deciphera Pharmaceuticals (DCPH) | 0.5 | $59M | 950k | 62.24 | |
| Fibrogen (FGEN) | 0.5 | $58M | 1.4M | 42.89 | |
| CVS Caremark Corporation (CVS) | 0.5 | $56M | 750k | 74.29 | |
| Ra Pharmaceuticals | 0.5 | $56M | 1.2M | 46.93 | |
| Momenta Pharmaceuticals | 0.4 | $54M | 2.8M | 19.73 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $52M | 400k | 129.04 | |
| ArQule | 0.4 | $50M | 2.5M | 19.96 | |
| Axsome Therapeutics (AXSM) | 0.4 | $46M | 442k | 103.36 | |
| Ptc Therapeutics Inc conv bd us | 0.4 | $46M | 40M | 1.16 | |
| Karuna Therapeutics Ord | 0.4 | $45M | 600k | 75.34 | |
| Fate Therapeutics (FATE) | 0.3 | $44M | 2.3M | 19.57 | |
| Progenics Pharmaceuticals | 0.3 | $42M | 8.3M | 5.09 | |
| Radius Health | 0.3 | $41M | 2.1M | 20.16 | |
| Cara Therapeutics (CARA) | 0.3 | $37M | 2.3M | 16.11 | |
| Tricida | 0.3 | $38M | 1.0M | 37.74 | |
| Sage Therapeutics (SAGE) | 0.3 | $36M | 500k | 72.19 | |
| Ptc Therapeutics I (PTCT) | 0.3 | $35M | 727k | 48.03 | |
| Karyopharm Therapeutics Inc note 3.000%10/1 | 0.3 | $34M | 24M | 1.43 | |
| Zealand Pharma A/s- | 0.3 | $34M | 1.0M | 33.20 | |
| Cypress Semiconductor Corp note 4.500% 1/1 | 0.3 | $32M | 19M | 1.74 | |
| Avrobio Ord (AVRO) | 0.2 | $31M | 1.6M | 20.13 | |
| Tiffany & Co. | 0.2 | $30M | 225k | 133.65 | |
| Instructure | 0.2 | $30M | 620k | 48.21 | |
| Invitae (NVTAQ) | 0.2 | $28M | 1.8M | 16.13 | |
| Veracyte (VCYT) | 0.2 | $28M | 1.0M | 27.92 | |
| D Stemline Therapeutics | 0.2 | $25M | 2.4M | 10.63 | |
| Ready Cap Corp Com reit (RC) | 0.2 | $25M | 1.6M | 15.42 | |
| Quotient | 0.2 | $24M | 2.5M | 9.51 | |
| Intercept Pharmaceuticals In Note 2.000 5/1 bnd | 0.2 | $23M | 18M | 1.32 | |
| Mirati Therapeutics | 0.2 | $23M | 175k | 128.86 | |
| Principia Biopharma | 0.2 | $22M | 400k | 54.78 | |
| Wright Medical Group Nv | 0.2 | $21M | 690k | 30.48 | |
| Crispr Therapeutics (CRSP) | 0.2 | $21M | 350k | 60.91 | |
| Savara (SVRA) | 0.2 | $22M | 4.8M | 4.48 | |
| Cypress Semiconductor Corporation | 0.2 | $20M | 840k | 23.33 | |
| Heron Therapeutics (HRTX) | 0.2 | $21M | 875k | 23.50 | |
| Nortonlifelock (GEN) | 0.1 | $18M | 720k | 25.52 | |
| Sprint | 0.1 | $17M | 3.2M | 5.21 | |
| Eiger Biopharmaceuticals | 0.1 | $16M | 1.1M | 14.90 | |
| Pacific Biosciences of California (PACB) | 0.1 | $15M | 3.0M | 5.14 | |
| Reata Pharmaceuticals Inc Cl A | 0.1 | $15M | 75k | 204.43 | |
| Apellis Pharmaceuticals (APLS) | 0.1 | $15M | 500k | 30.62 | |
| Livongo Health | 0.1 | $15M | 600k | 25.06 | |
| Exagen (XGN) | 0.1 | $15M | 578k | 25.40 | |
| Uniqure Nv (QURE) | 0.1 | $14M | 200k | 71.66 | |
| Clovis Oncology Inc note 1.250% 5/0 | 0.1 | $12M | 19M | 0.64 | |
| LogMeIn | 0.1 | $11M | 130k | 85.74 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $11M | 1.5M | 7.05 | |
| Optinose (OPTN) | 0.1 | $8.3M | 900k | 9.22 | |
| Sanofi Aventis Wi Conval Rt | 0.1 | $7.9M | 9.2M | 0.86 | |
| Rocket Pharmaceuticals (RCKT) | 0.1 | $8.1M | 354k | 22.76 | |
| Gossamer Bio (GOSS) | 0.1 | $7.8M | 500k | 15.63 | |
| Dermtech Ord ord (DMTK) | 0.1 | $7.6M | 615k | 12.40 | |
| Abeona Therapeutics | 0.1 | $6.5M | 2.0M | 3.27 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.1 | $6.3M | 100k | 63.43 | |
| Radius Health Inc note 3.000% 9/0 | 0.1 | $5.8M | 6.8M | 0.86 | |
| Phasebio Pharmaceuticals (PHASQ) | 0.1 | $6.1M | 1.0M | 6.11 | |
| Oyster Point Pharma | 0.1 | $5.6M | 231k | 24.44 | |
| Atara Biotherapeutics (ATRA) | 0.0 | $5.5M | 335k | 16.47 | |
| Xerox Corp (XRX) | 0.0 | $4.8M | 130k | 36.87 | |
| Opko Health (OPK) | 0.0 | $3.7M | 2.5M | 1.47 | |
| Zafgen | 0.0 | $2.0M | 1.8M | 1.11 | |
| Broadmark Rlty Cap Inc *w exp 11/15/202 | 0.0 | $2.7M | 7.2M | 0.38 | |
| Aptinyx | 0.0 | $1.4M | 409k | 3.42 | |
| Cyclerion Therapeutics | 0.0 | $952k | 350k | 2.72 |
